Rhinomed (ASX:RNO) Shares Up 3.1%

Rhinomed Ltd (ASX:RNO) shares shot up 3.1% during trading on Thursday . The stock traded as high as A$0.17 ($0.12) and last traded at A$0.17 ($0.12), 97,499 shares traded hands during trading. A decline of 20% from the average session volume of 122,418 shares. The stock had previously closed at A$0.16 ($0.11).

The firm has a fifty day simple moving average of A$0.19 and a 200 day simple moving average of A$0.24. The company has a market capitalization of $27.07 million and a PE ratio of -3.56.

In other news, insider Eric Knight 1,000,000 shares of the company’s stock in a transaction dated Friday, January 24th.

Rhinomed Company Profile (ASX:RNO)

Rhinomed Limited, a medical technology company, researches, develops, and commercializes consumer and medical devices. The company identifies, acquires, and commercializes late stage therapeutic delivery technologies. It markets Turbine, a nasal dilator designed to assist to breathe easier during aerobic exercise; and Mute, a nasal dilator designed to enhance sleep quality by breathing more and snoring less.

Read More: What is a Call Option?

Receive News & Ratings for Rhinomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhinomed and related companies with MarketBeat.com's FREE daily email newsletter.